Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (603168.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.74B
Enterprise Value2.94B
P/E Ratio-7.17
PEG Ratio0.03
Price/Sales Ratio4.27
Price/Book Ratio1.48
Enterprise/Revenue4.64
Enterprise/EBITDA-9.13

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.6
Operating Margin-0.63
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.19

Income Statement

Revenue460.16M
Revenue/Share1.23
Gross Profit186.4M
EBITDA40M
Net Income-238.72M
Diluted EPS-0.64

Balance Sheet

Total Cash121.03M
Total Cash/Share0.32
Total Debt239.46M
Total Debt/Equity0.18
Current Ratio0.89
Book Value Per Share3.55

Price History

52-Week Change-28.08
52-Week High9.09
52-Week Low4.83
Moving Average 50 Days6.16
Moving Average 200 Days7.28

Statistics

Average Volume7.63M
Shares Outstanding374.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.01
Last Split Factor13:10
Last Split DateJune 08, 2018
AD